Gynix

ANDA 73249, held by Teva Pharms. Clotrimazole.

As of Nov 15, 2026, ANDA 73249 (Gynix), held by Teva Pharms, was first approved by FDA on Feb 13, 1998, with 1 approved supplement and 0 published complete response letters.

• First approved: Feb 13, 1998
• Supplements approved: 1
• Complete response letters: 0

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters